Literature DB >> 2689347

Nosocomial infections due to Serratia marcescens--clinical findings, antibiotic susceptibility patterns and fine typing.

R Bollmann1, E Halle, W Sokolowska-Köhler, E L Grauel, P Buchholz, I Klare, H Tschäpe, W Witte.   

Abstract

We report on nosocomial infections caused by Serratia marcescens occurring in a neonatal intensive care unit and a children's ward for cardiac intensive care. According to the plasmid pattern analysis, all isolated epidemic strains belonged to one clone. Multi-drug resistance, even to cephalosporins of the third generation and amikacin, was characteristic for all strains. Certain markers of S. marcescens (haemolysin, proteases, siderophores) which are thought to be related to virulence were studied but will require further investigation.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2689347     DOI： 10.1007/bf01650711

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  24 in total

1.  Iron regulation of Serratia marcescens hemolysin gene expression.

Authors:  K Poole; V Braun
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

2.  [Broth microdilution test for the standardized determination of minimal inhibitory and minimal bactericidal concentrations of antimicrobial drugs in rapidly growing aerobic bacteria].

Authors:  I Klare; W Witte
Journal:  Z Gesamte Hyg       Date:  1988-02

3.  Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections.

Authors:  W König; Y Faltin; J Scheffer; H Schöffler; V Braun
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 4.  Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.

Authors:  F Lindberg; S Normark
Journal:  Rev Infect Dis       Date:  1986 Jul-Aug

5.  [Methods of beta-lactamase detection in bacterial].

Authors:  I Klare; W Witte
Journal:  Z Gesamte Hyg       Date:  1984-08

6.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

7.  [Perinatal infections caused by rare agents. 2. Serratia marcescens].

Authors:  W Handrick; L Bergmann; F B Spencker
Journal:  Padiatr Grenzgeb       Date:  1981

8.  [Nosocomial infections caused by multi-resistant Serratia marcescens at a university clinic--clinical aspects and drug resistance].

Authors:  E Halle; E L Grauel; I Klare; R Bollmann; P Buchholz; W Scholowska-Köhler; W Witte; B Göldner; B Baumann
Journal:  Padiatr Grenzgeb       Date:  1989

9.  A new test based on 'salting out' to measure relative surface hydrophobicity of bacterial cells.

Authors:  M Lindahl; A Faris; T Wadström; S Hjertén
Journal:  Biochim Biophys Acta       Date:  1981-11-05

10.  Further differentiation of Enterobacteriaceae by means of siderophore-pattern analysis.

Authors:  R Reissbrodt; W Rabsch
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-05
View more
  10 in total

1.  Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.

Authors:  J H Kim; E H Cho; K S Kim; H Y Kim; Y M Kim
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

Review 2.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Application of infrequent-restriction-site PCR to clinical isolates of Acinetobacter baumannii and Serratia marcescens.

Authors:  J H Yoo; J H Choi; W S Shin; D H Huh; Y K Cho; K M Kim; M Y Kim; M W Kang
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

4.  Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit.

Authors:  G Miranda; C Kelly; F Solorzano; B Leanos; R Coria; J E Patterson
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

5.  Proteolytic activity in Serratia marcescens clinical isolates.

Authors:  R Coria-Jiménez; C Zárate-Aquino; O Ponce-Ponce
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

6.  Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens.

Authors:  R Alonso; H M Aucken; J C Perez-Diaz; B D Cookson; F Baquero; T L Pitt
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

7.  Genetic and structural characterization of the core region of the lipopolysaccharide from Serratia marcescens N28b (serovar O4).

Authors:  Núria Coderch; Núria Piqué; Buko Lindner; Nihal Abitiu; Susana Merino; Luis Izquierdo; Natalia Jimenez; Juan M Tomás; Otto Holst; Miguel Regué
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

8.  Epidemiological survey of an outbreak of multiresistant Serratia marcescens by PCR-fingerprinting.

Authors:  S B Debast; W J Melchers; A Voss; J A Hoogkamp-Korstanje; J F Meis
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

9.  Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.

Authors:  R Coria-Jiménez; C Ortiz-Torres
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

10.  Recent independent emergence of multiple multidrug-resistant Serratia marcescens clones within the United Kingdom and Ireland.

Authors:  Danesh Moradigaravand; Christine J Boinett; Veronique Martin; Sharon J Peacock; Julian Parkhill
Journal:  Genome Res       Date:  2016-07-18       Impact factor: 9.043
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.